1 week Ago By Defense World Staff
American Century Companies Inc. boosted its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) by 13.
2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,410 shares of the company’s stock after buying an additional 3,072 shares during the period. American Century Companies Inc.
owned approximately 0.11% of OrthoPediatrics worth $612,000 as of its most recent SEC filing. A number of other large investors have also recently made changes to their positions in the business.
HighTower Advisors LLC acquired a new stake in shares of OrthoPediatrics in the 4th quarter worth about $268,000. Charles Schwab Investment Management Inc. raised its stake in shares of OrthoPediatrics by 2.
9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,234 shares of the company’s stock worth $3,158,000 after purchasing an additional 3,800 shares during the last quarter.
Mutual of America Capital Management LLC lifted its holdings in shares of OrthoPediatrics by 57.1% in the fourth quarter. Mutual of America Capital Management LLC now owns 169,021 shares of the company’s stock valued at $3,918,000 after purchasing an additional 61,412 shares in the last quarter.
Bank of New York Mellon Corp boosted its position in shares of OrthoPediatrics by 3.8% during the fourth quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company’s stock valued at $1,338,000 after buying an additional 2,099 shares during the last quarter.
Finally, AlphaCentric Advisors LLC bought a new stake in OrthoPediatrics during the fourth quarter worth $171,000. 69.05% of the stock is owned by institutional investors.
OrthoPediatrics Price PerformanceKIDS opened at $21.16 on Friday. OrthoPediatrics Corp.
has a fifty-two week low of $20.78 and a fifty-two week high of $35.99.
The firm has a 50-day moving average of $24.20 and a 200 day moving average of $24.76.
The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.
17. The firm has a market cap of $513.91 million, a P/E ratio of -17.
20 and a beta of 1.17. OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last released its earnings results on Tuesday, March 4th.
The company reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.
04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.
78%. The firm had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.
16 million. During the same period in the previous year, the company earned ($0.23) earnings per share.
On average, research analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.
Insider Buying and Selling at OrthoPediatricsIn other news, CFO Fred Hite sold 6,443 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $160,172.
98. Following the sale, the chief financial officer now owns 207,989 shares of the company’s stock, valued at $5,170,606.54.
The trade was a 3.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Also, CEO David R. Bailey sold 6,620 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.
86, for a total transaction of $164,573.20. Following the completion of the transaction, the chief executive officer now directly owns 319,155 shares of the company’s stock, valued at approximately $7,934,193.
30. This trade represents a 2.03 % decrease in their ownership of the stock.
The disclosure for this sale can be found here. Over the last ninety days, insiders sold 23,732 shares of company stock valued at $589,978. Company insiders own 31.
80% of the company’s stock. Analyst Upgrades and DowngradesSeveral brokerages have weighed in on KIDS. Lake Street Capital started coverage on OrthoPediatrics in a research note on Monday, April 7th.
They set a “buy” rating and a $37.00 price objective on the stock. Needham & Company LLC reissued a “buy” rating and set a $42.
00 price target on shares of OrthoPediatrics in a research report on Wednesday. Stifel Nicolaus reduced their price objective on shares of OrthoPediatrics from $40.00 to $32.
00 and set a “buy” rating for the company in a research report on Wednesday, March 5th. Finally, Truist Financial dropped their target price on shares of OrthoPediatrics from $26.00 to $24.
00 and set a “hold” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.
com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $37.00.Check Out Our Latest Research Report on KIDSOrthoPediatrics Company Profile (Free Report)OrthoPediatrics Corp.
, a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.Recommended StoriesFive stocks we like better than OrthoPediatricsHow to Use the MarketBeat Dividend CalculatorJPMorgan is a Buy, if You Can Handle The Volatility Insider Selling Explained: Can it Inform Your Investing Choices?United States Steel’s Crash: An Unmissable Buying OpportunityREIT Stocks – Best REIT Stocks to Add to Your Portfolio TodayRocket Lab Stock: Weathering the Storm, Time for a Comeback?Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report)..
